Translational Development Acquisition Corp.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TDAC and other ETFs, options, and stocks.About TDAC
Translational Development Acquisition Corp. is a blank check company that was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 19, 2022 and is headquartered in New York, NY.
CEOMichael B. Hoffman
CEOMichael B. Hoffman
Employees2
Employees2
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2022
Founded2022
Employees2
Employees2
TDAC Key Statistics
Market cap229.59M
Market cap229.59M
Price-Earnings ratio48.27
Price-Earnings ratio48.27
Dividend yield—
Dividend yield—
Average volume1.87K
Average volume1.87K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$10.49
52 Week high$10.49
52 Week low$10.00
52 Week low$10.00
Stock Snapshot
With a market cap of 229.59M, Translational Development Acquisition Corp.(TDAC) trades at $10.48. The stock has a price-to-earnings ratio of 48.27.
On 2026-01-16, Translational Development Acquisition Corp.(TDAC) stock opened at —, reached a high of —, and a low of —.
Translational Development Acquisition Corp.(TDAC) shares are trading with a volume of 0, against a daily average of 1.87K.
During the past year, Translational Development Acquisition Corp.(TDAC) stock moved between $10.00 at its lowest and $10.49 at its peak.
During the past year, Translational Development Acquisition Corp.(TDAC) stock moved between $10.00 at its lowest and $10.49 at its peak.
People also own
Based on the portfolios of people who own TDAC. This list is generated using Robinhood data, and it’s not a recommendation.